Authors :
Braillon A, Alcohol Treatment Unit, University Hospital, Amiens, France
Granger B, Psychiatry, Tarnier Hospital (AP-HP), Paris, France
Published Date June 2015 Volume 2015:6 Pages 75—80
Dear editor
“A great deal of intelligence can be invested in ignorance when the need for illusion is deep”. Saul Bellow
Paille and Martini’s review on nalmefene for alcohol dependence deserves some comment.1
First, the authors stated no conflict of interest despite both repeatedly received money from Lundbeck laboratories, the company marketing nalmefene (eg, http://www.lundbeck.com/fr/a-propos-de-lundbeck/transparence-des-liens and https://www.transparence.sante.gouv.fr/flow/main?execution=e2s1). We recently challenged such unprofessional behavior in a French journal where authors also masked their conflicts of interest and provided an inaccurate analysis.2
Second, the data analysis is flawed and failed to discuss the limitations.
More : Nalmefene and alcohol dependence: a new approach or the same old unacceptable marketing?